The FDA is reexamining the safety of two approved RSV antibodies for infants, the latest move by the agency to scrutinize approved preventive products used

The FDA’s investigation of Covid-19 vaccine safety in children has expanded into adults, according to people familiar with the agency’s work — a significant widening

ORLANDO, Fla. — Clinical trials in multiple myeloma continue to rapidly progress, and nowhere was this more apparent than at the American Society of Hematology’s

UK-based cell therapy manufacturer Cellular Origins has raised $40 million in an over-subscribed Series A to expand to the US and secure more company partnerships.

Just a month after announcing a deal with Eli Lilly to work on RNAi drugs for metabolic diseases, China’s SanegeneBio has disclosed a $110 million